HEALTHCARE DISTRIBUTION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• In January 2023, Amylyx Pharmaceuticals, Inc., a pharmaceutical company, finalized an exclusive license and distribution agreement with Neopharm for the commercialization of AMX0035 (sodium phenylbutyrate and ursodoxicoltaurine) in Israel, Gaza, West Bank, and the Palestinian Authority, pending regulatory review and approval. AMX0035 is intended for the treatment of amyotrophic lateral sclerosis (ALS).
• In January 2023, Open Medical announced a strategic partnership with Tamer Group, a healthcare and beauty care company, to introduce its award-winning Digital Transformation (KSA) solution in the Kingdom of Saudi Arabia. This initiative aims to support Saudi Arabia's healthcare innovators in enhancing the effectiveness and quality of healthcare services, thus, facilitating Open Medical's business expansion.
• In May 2022, AAH Pharmaceuticals, a key player in the wholesale distribution of medications in the U.K., formed a partnership with RELEX Solutions. AAH Pharmaceuticals utilizes RELEX to optimize forecasting and replenishment processes across more than 1,000 suppliers. This partnership supports demand and supply planning across various product categories, including managing factors like seasonality and promotional activities. The aim is to enhance operational efficiency by smoothing delivery flows.
• In April 2021, Diethelm Keller Siebel Hegner successfully acquired a South Korea-based life sciences retailer, solidifying its position as a premier supplier of scientific instruments throughout Asia. a Singapore-based medical device supplier completed the acquisition of Medworks, a retailer, further bolstering its business expansion efforts.